[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350320-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350320-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cause-specific-mortality-in-a-population-level-cohort-of-pancreatic-cancer-patients-following-chemotherapy-a-seer-based-study","Cause-specific mortality in a population-level cohort of pancreatic cancer patients following chemotherapy - A SEER-based study","","Pancreatic adenocarcinoma remains highly lethal, and the way modern chemotherapy alters the complete mortality profile, including competing non-cancer deaths, is incompletely characterized. Using Surveillance, Epidemiology, and End Results (2010–2021), adults with primary pancreatic adenocarcinoma receiving systemic chemotherapy were analyzed by cause of death and stage. Among 8218 deaths over median 14.2 months, pancreatic cancer predominated, while non-cancer causes were time-dependent and elevated, especially in year 1, driven by cardiovascular and infectious diseases.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cause-specific-mortality-in-a-population-level-cohort-of-pancreatic-cancer-patients-following-chemotherapy-a-seer-based-study/350320/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cause-specific-mortality-in-a-population-level-cohort-of-pancreatic-cancer-patients-following-chemotherapy-a-seer-based-study/350320.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What dataset and time period were used to study cause-specific mortality in chemotherapy-treated pancreatic cancer patients?","Question",{"text":63,"@type":64},"The analysis used Surveillance, Epidemiology, and End Results (SEER) data from 2010–2021 to follow adults with primary pancreatic adenocarcinoma who received systemic chemotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were deaths classified in the study?",{"text":68,"@type":64},"Cause of death was categorized using the International Classification of Diseases, Tenth Revision into pancreatic cancer, other cancers, or non-cancer causes.",{"name":70,"@type":61,"acceptedAnswer":71},"Which non-cancer death causes contributed most and when did their risk peak?",{"text":72,"@type":64},"Non-cancer mortality showed the greatest relative burden in year 1, with cardiovascular causes (heart and cerebrovascular disease) and infectious causes (e.g., septicemia, pneumonia/influenza) carrying substantial risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350320,1790379667,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","®  \n Observational Study   \nCause-specific mortality in a population-level cohort of pancreatic cancer patients following chemotherapy  \nA SEER-based study  \nZhirong Gao, PhDa ,* , Liye Bei, PhDb , Kaili Peng, MDa  \n\n| Abstract\u003Cbr>Pancreatic adenocarcinoma remains highly lethal. How modern chemotherapy reshapes the full mortality profile, including competing non‑cancer deaths, is incompletely defined. Using Surveillance, Epidemiology, and End Results (2010–2021), we identified 9624 adults (20–89 years) with primary pancreatic adenocarcinoma who received systemic chemotherapy. Cause of death (International Classification of Diseases, Tenth Revision) was classified as pancreatic cancer, other cancers, or non‑cancer causes. Stage‑stratified analyses characterized mortality heterogeneity. Standardized mortality ratios (SMRs) versus the general US population were calculated in SEER*Stat; multivariable Poisson regression assessed risk factors. Temporal patterns were examined across ≤1 year, 1 to 5 years, and >5 years from diagnosis. Over a median follow‑up of 14.2 months, 8218 deaths occurred. Pancreatic cancer accounted for 90.6%(n = 7448); non‑cancer causes accounted for 6. 1%(n = 498), and other cancers accounted for 3.3%(n = 272) . Non‑cancer mortality comprised 7.8% of stage I/II deaths versus 5. 1% in stage III/IV, reflecting longer survival enabling competing risks. Overall, non‑cancer mortality was markedly elevated (SMR 15.38, 95% confidence interval: 14.06–16.79), peaking in year 1 (SMR 96. 10) and declining thereafter (1–5 years, SMR 13.63; >5 years, SMR 3. 19) . Cardiovascular deaths carried the greatest non‑cancer burden (heart disease SMR 9.96; cerebrovascular disease SMR 12.7) . Infectious causes showed the highest relative risks (septicemia SMR 20.3; pneumonia/influenza SMR 88.69), concentrated in the first year. Chronic obstructive pulmonary disease (SMR 17.57) and diabetes (SMR 19.3) were additional contributors. Older patients (70–89 years) experienced the steepest early mortality. Suicide risk was strikingly increased (SMR 113.68), underscoring substantial psychological distress. In chemotherapy‑treated pancreatic cancer, non‑cancer mortality is substantial, time‑dependent, and dominated by cardiovascular and infectious causes in the first year after diagnosis. These data support integrated cardio‑oncology pathways, aggressive infection prevention, metabolic and pulmonary co‑management, and early psychosocial interventions to reduce preventable deaths and improve outcomes. |\n| --- |\n| Abbreviations: CI = confidence interval, COPD = chronic obstructive pulmonary disease, FOLFIRINOX = fluorouracil , leucovorin, irinotecan, and oxaliplatin, SEER = Surveillance, Epidemiology, and End Results, SMR = standardized mortality ratio. |\n| Keywords: cardiotoxicity, cause‑specific mortality, infectious complications, pancreatic adenocarcinoma, stage‑stratified analysis, standardized mortality ratio |\n\n1. Introduction  \nPancreatic adenocarcinoma remains among oncology’s most formidable challenges, with therapeutic advances modest  \ncompared with those for other malignancies despite decades of intensive research. [1] With approximately 466,000 deaths annually worldwide, pancreatic cancer ranks as the seventh leading cause of cancer-related mortality globally, yet its clinical impact  \nThe authors have no conflicts of interest to disclose.  \nThis work was supported by the Hangzhou Medical and Health Science and Technology Project, under the supervision of the Hangzhou Municipal Health Commission, China (Fund No. B20262685).  \nThe datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.  \nThis study utilized deidentified data from the publicly available Surveillance, Epidemiology, and End Results (SEER) database. The SEER program operates under appropriate ethical oversight, with participating registries maintaining Institutional Review Board (IRB) approval for","cbCaif92BD5hNrZb","https://ap.wps.com/l/cbCaif92BD5hNrZb","pdf",1442718,11,"English","# Introduction\n## Methods\n## Results\n## Discussion\n## Abbreviations and Keywords","[{\"question\":\"What dataset and time period were used to study cause-specific mortality in chemotherapy-treated pancreatic cancer patients?\",\"answer\":\"The analysis used Surveillance, Epidemiology, and End Results (SEER) data from 2010–2021 to follow adults with primary pancreatic adenocarcinoma who received systemic chemotherapy.\"},{\"question\":\"How were deaths classified in the study?\",\"answer\":\"Cause of death was categorized using the International Classification of Diseases, Tenth Revision into pancreatic cancer, other cancers, or non-cancer causes.\"},{\"question\":\"Which non-cancer death causes contributed most and when did their risk peak?\",\"answer\":\"Non-cancer mortality showed the greatest relative burden in year 1, with cardiovascular causes (heart and cerebrovascular disease) and infectious causes (e.g., septicemia, pneumonia/influenza) carrying substantial risk.\"}]","Cause-specific mortality in a population-level cohort of pancreatic cancer patients following chemotherapy - A SEER-based study | PDF",1790088435,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b03442b5e3672b1b7fcede61ff9d438d.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/507e2501c33fb294950a0fd67cad7156.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/877330407b926ad9b32a8c990ffe1aaa.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2baaa5377f6099957ce62d48f55cf9bf.webp",980,1306]